Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 15.
doi: 10.1002/ksa.12724. Online ahead of print.

Long-term clinical and MRI outcomes of a polyurethane meniscal scaffold implantation for the treatment of partial meniscal deficiency: A minimum 10-year follow-up study

Vasileios S Akrivos  1 , George A Komnos  1 , Bela Ujvari  2 , Artemis Hante  3 , Eleftheria Adaktylidou  1 , Theofilos Karachalios  1 , Michael Hantes  1
Affiliations

Long-term clinical and MRI outcomes of a polyurethane meniscal scaffold implantation for the treatment of partial meniscal deficiency: A minimum 10-year follow-up study

Vasileios S Akrivos et al. Knee Surg Sports Traumatol Arthrosc. .

Abstract

Purpose: To assess the clinical and magnetic resonance imaging (MRI) results after implantation of a polyurethane scaffold for chronic segmental meniscus deficiency following partial meniscectomy in a long-term follow-up.

Study design: Level IV, retrospective case series.

Methods: Thirty-two knees received arthroscopic implantation of an Actifit® polyurethane meniscal implant for deficiency of the meniscus. Clinical outcomes were assessed using patient-reported outcome scores, including Knee injury and Osteoarthritis Outcome Score (KOOS), Lysholm, Tegner Activity Scale and visual analogue scale (VAS) for pain and satisfaction. Preoperative MRI scans and final follow-up radiographs and MRI evaluations were performed to assess scaffold morphology, tissue integration and the status of the articular cartilage.

Results: The mean follow-up was 11.4 years. Significant improvements were observed in clinical outcomes, with KOOS improving from a preoperative mean of 47.75 (standard deviation [SD]: 16.88) to a 78.62 (SD: 15.45), Lysholm scores from 46.62 (SD: 16.96) to 84.62 (SD: 13.03), Tegner Activity Scale improving from 1.8 to 4.1 at the final follow-up. The VAS for pain decreased from a preoperative mean of 5.62 (SD: 2.54) to 2.12 (SD: 2.02). MRI evaluations using the Genovese classification showed 23 knees with Type II scaffolds, 0 with Type III and 9 with Type I. Bone oedema was not present in 27 knees, with 5 knees showing Type I bone oedema. Meniscal extrusion was observed in 24 knees with partial extrusion and 8 knees with complete extrusion. The contralateral meniscus was normal in 28 knees and graded as Reicher Grade 1 in 2 knees. The Kellgren-Lawrence classification revealed 15 knees with Type I osteoarthritic changes, 10 with Type II changes and 7 with Type III changes.

Conclusion: Arthroscopic treatment for patients with chronic segmental meniscal loss using a polyurethane meniscal implant can achieve sustainable long-term results regarding pain reduction and knee function. However, the MRI did not reveal normal menisci in all cases.

Level of evidence: Level IV.

Keywords: Actifit; irreparable meniscal defect; meniscus; partial meniscectomy; polyurethane scaffold; scaffold.

PubMed Disclaimer

Similar articles

See all similar articles

References

REFERENCES

    1. Baynat C, Andro C, Vincent JP, Schiele P, Buisson P, Dubrana F, et al. Actifit synthetic meniscal substitute: experience with 18 patients in Brest, France. Orthop Traumatol Surg Res. 2014;100:S385–S389.
    1. Bouyarmane H, Beaufils P, Pujol N, Bellemans J, Roberts S, Spalding T, et al. Polyurethane scaffold in lateral meniscus segmental defects: clinical outcomes at 24 months follow‐up. Orthop Traumatol Surg Res. 2014;100:153–157.
    1. Bulgheroni E, Grassi A, Campagnolo M, Bulgheroni P, Mudhigere A, Gobbi A. Comparative study of collagen versus synthetic‐based meniscal scaffolds in treating meniscal deficiency in young active population. Cartilage. 2016;7:29–38.
    1. de Caro F, Perdisa F, Dhollander A, Verdonk R, Verdonk P. Meniscus scaffolds for partial meniscus defects. Clin Sports Med. 2020;39:83–92.
    1. de Chanterac A, Garetier M, Gunepin FX, Baynat C, Danguy des Déserts M, Perchoc A, et al. ACTIfit™: 38% full resorption at 8 years in a cohort of 18 cases. Orthop Traumatol Surg Res. 2023;109:103616.

LinkOut - more resources